These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 14668422)

  • 1. Duration of venous thromboembolism prophylaxis after surgery.
    Kearon C
    Chest; 2003 Dec; 124(6 Suppl):386S-392S. PubMed ID: 14668422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.
    Douketis JD; Eikelboom JW; Quinlan DJ; Willan AR; Crowther MA
    Arch Intern Med; 2002 Jul; 162(13):1465-71. PubMed ID: 12090882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.
    Raskob GE; Hirsh J
    Chest; 2003 Dec; 124(6 Suppl):379S-385S. PubMed ID: 14668421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous thromboembolism in the orthopedic surgery patient.
    Deitelzweig SB; McKean SC; Amin AN; Brotman DJ; Jaffer AK; Spyropoulos AC
    Cleve Clin J Med; 2008 Apr; 75 Suppl 3():S27-36. PubMed ID: 18494224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis prophylaxis: better living through chemistry--in the affirmative.
    Kwong LM
    J Arthroplasty; 2005 Jun; 20(4 Suppl 2):12-4. PubMed ID: 15991121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
    Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
    N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery.
    Dranitsaris G; Stumpo C; Smith R; Bartle W
    Am J Cardiovasc Drugs; 2009; 9(1):45-58. PubMed ID: 19178131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
    Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
    Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
    Nutescu EA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
    Anderson FA; Hirsh J; White K; Fitzgerald RH;
    Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
    Kaatz S; Spyropoulos AC
    Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.